Nonalcoholic fatty liver disease (NAFLD) is estimated to affect 1/3 of the US adult population. In this high-fat environment, hepatic mitochondria and peroxisomes are thought to work in concert to prevent lipid accumulation;however, enhanced peroxisomal activity generates reactive oxygen species (ROS) and may have damaging effects on hepatocytes. Exercise is considered among the best treatments for NAFLD, but there is little molecular explanation for its benefits. We have developed a mitochondrial trifunctional protein (catalyzes last 3 steps in beta-oxidation) heterozygous mouse (MTPa) that develops NAFLD and insulin resistance due to impairment in mitochondrial fatty acid oxidation and accumulation of long chain fatty acid metabolites. The central hypothesis of this proposal is that daily exercise increases hepatic mitochondrial biogenesis in MTPa mice resulting in increased mitochondrial fatty acid oxidative capacity and reduced trafficking of fatty acids through peroxisomal pathways culminating in reduced hepatic-oxidative stress, -steatosis, and liver injury. We also postulate that this reduced hepatic oxidative stress will improve hepatic insulin signaling and whole body insulin sensitivity. MTP and MTP mice will either voluntarily exercise on running wheels or remain sedentary for 6 months. Measures of hepatic mitochondrial biogenesis and peroxisomal proliferation and fatty acid oxidative capacity will be assessed, along with hepatic lipid peroxidation and oxidative stress. MTP mice also will undergo hyperinsulinemic-euglycemic clamps to assess the influence of exercise on hepatic insulin signaling and whole-body insulin sensitivity. The long-term goal of this project is to explore mechanisms linked to reduced severity of hepatic steatosis with exercise training.
It also is estimated that more than 10 million Americans have disorders in mitochondrial fatty acid oxidation and 90 million US adults have NAFLD. Unfortunately, the effectiveness and biological mechanisms of current treatments are largely unknown. It is the focus of this project to identify potential mechanisms and therapeutic targets by which exercise can reduce the incidence of NAFLD by increasing hepatic mitochondrial function, reduce liver injury, and improve hepatic insulin sensitivity.
|Linden, Melissa A; Meers, Grace M; Ruebel, Meghan L et al. (2013) Hepatic steatosis development with four weeks of physical inactivity in previously active, hyperphagic OLETF rats. Am J Physiol Regul Integr Comp Physiol 304:R763-71|
|Rector, R Scott; Morris, E Matthew; Ridenhour, Suzanne et al. (2013) Selective hepatic insulin resistance in a murine model heterozygous for a mitochondrial trifunctional protein defect. Hepatology 57:2213-23|
|Perfield 2nd, James W; Ortinau, Laura C; Pickering, R Taylor et al. (2013) Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice. J Obes 2013:296537|
|Borengasser, Sarah J; Rector, R Scott; Uptergrove, Grace M et al. (2012) Exercise and Omega-3 Polyunsaturated Fatty Acid Supplementation for the Treatment of Hepatic Steatosis in Hyperphagic OLETF Rats. J Nutr Metab 2012:268680|
|Mikus, Catherine R; Roseguini, Bruno T; Uptergrove, Grace M et al. (2012) Voluntary wheel running selectively augments insulin-stimulated vasodilation in arterioles from white skeletal muscle of insulin-resistant rats. Microcirculation 19:729-38|
|Rector, R Scott; Uptergrove, Grace M; Morris, E Matthew et al. (2011) Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model. Am J Physiol Gastrointest Liver Physiol 300:G874-83|
|Bender, Shawn B; Newcomer, Sean C; Harold Laughlin, M (2011) Differential vulnerability of skeletal muscle feed arteries to dysfunction in insulin resistance: impact of fiber type and daily activity. Am J Physiol Heart Circ Physiol 300:H1434-41|
|Morris, E Matthew; Rector, R Scott; Thyfault, John P et al. (2011) Mitochondria and redox signaling in steatohepatitis. Antioxid Redox Signal 15:485-504|
|Rector, R Scott; Ibdah, Jamal A (2010) Fatty acid oxidation disorders: maternal health and neonatal outcomes. Semin Fetal Neonatal Med 15:122-8|
|Rector, R Scott; Thyfault, John P; Uptergrove, Grace M et al. (2010) Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol 52:727-36|
Showing the most recent 10 out of 20 publications